What's breaking now, across thousands of outlets.
Indian drugmaker Gujarat Themis Biosyn Ltd. has obtained private credit funding to back its purchase of Japanese peer MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
The number of confirmed Ebola cases in the Congo continues to rise, as does the number of deaths. However, in one particularly affected region, there is a hopeful development.
Many cancers associated with infection are preventable
The Tampa Bay Buccaneers are one of the NFL’s most short-handed teams after Baker Mayfield’s injury was announced and a Jalen McMillan knee injury became part of an ugly loss to the Vikings.
The allegations come amid an aggressive, statewide enforcement drive by the FDA, targeting hygiene violations, food adulteration, and unsafe products.
